CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
112 hedge funds and large institutions have $1.52B invested in Clovis Oncology, Inc. in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 21 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
34% less call options, than puts
Call options by funds: $9.63M | Put options by funds: $14.6M
Holders
112
Holding in Top 10
2
Calls
$9.63M
Puts
$14.6M
Top Buyers
| 1 | +$33.5M | |
| 2 | +$31.3M | |
| 3 | +$17.9M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$13.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.5M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$10.3M | |
| 3 | -$9.89M | |
| 4 |
HM
HealthCor Management
New York
|
-$9.49M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.01M |